Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Removing the Cervix During a Hysterectomy May Be Redundant

By HospiMedica International staff writers
Posted on 05 Jan 2009
Cervix removal during hysterectomy may not be necessary, according to the results of a follow-up survey of a randomized trial.

Researchers at the Mayday University Hospital (Croydon, United Kingdom), the University of Sussex (Brighton, UK), and St George's University of London (United Kingdom) compared the long-term outcomes of a randomized, double blind, multi-center trial in 279 women who underwent total abdominal hysterectomy (TAH) or subtotal abdominal hysterectomy (sub-TAH). More...
Participants were invited to complete questionnaires regarding quality of life and pelvic organ function. Of the 181 women (65% of participants) who completed the study, 90 had undergone TAH and 91 underwent sub-TAH; mean follow-up was 9 years (range, 7 - 11 years).

The study results showed that quality of life, mental health, and pelvic organ function were not significantly different between the TAH and sub-TAH groups. Although urinary and bowel function did not change significantly over time, there were significant decreases in both groups in a variety of sexual function parameters, pain, and role limitations, which were attributed to emotional problems. The researchers also found that sub-TAH was technically easier and associated with quicker recovery, but that 7% of women who underwent sub-TAH experienced cyclical vaginal discharge or bleeding. The study was published in the December 2008 issue of Obstetrics & Gynecology.

"There were no long-term differences in outcomes between TAH and sub-TAH,” said lead author Ranee Thakar, M.D., of the department of obstetrics and gynecology at Mayday University Hospital. "The lack of a detrimental effect on bowel and urinary function seen at 12 months was maintained. The deterioration in sexual function is likely to be due to the climacteric.”

"Despite the proliferation in recent years of effective, less invasive, and cheaper surgical and nonsurgical alternatives to treat menorrhagia, hysterectomy remains the most common major gynecological operation performed in the United States and in the United Kingdom,” added the authors. "This is because research has shown that it is a definitive cure for a wide range of gynecological disorders with a low perioperative morbidity, high satisfaction rate, and improved quality of life.”

Related Links:
Mayday University Hospital
University of Sussex
St. George's University of London


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.